Fig. 2From: Randomized, placebo-controlled, double-blind, pilot trial to investigate safety and efficacy of Cerebrolysin in patients with aneurysmal subarachnoid hemorrhageDistribution of six-month GOSE and mRS global functional outcomes for Cerebrolysin and saline group subjectsBack to article page